Respiratory symptoms, smoking history and airflow limitation: How should we define COPD?

L. Vanfleteren, F. Franssen, G. Rohde, E. Wouters (Maastricht, Horn, Netherlands)

Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Session: Respiratory epidemiology: methods, definitions and phenotypes
Session type: Thematic Poster Session
Number: 4159
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Vanfleteren, F. Franssen, G. Rohde, E. Wouters (Maastricht, Horn, Netherlands). Respiratory symptoms, smoking history and airflow limitation: How should we define COPD?. Eur Respir J 2011; 38: Suppl. 55, 4159

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 250s
Year: 2002

The interaction between family history of COPD, personal smoking and post-bronchodilator airflow obstruction: A cohort study
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007



Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Chronic airflow limitation and respiratory symptoms among smokers and never smokers
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019

Smoking, asthma, chronic airflow obstruction and COPD
Source: Eur Respir J 2015; 45: 586-588
Year: 2015


Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002



Passive smoking and respiratory symptoms in the FinEsS Study
Source: Eur Respir J 2003; 21: 672-676
Year: 2003



The importance of dyspnea and airflow limitation for anxiety and depression in COPD
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


Efficacy of confronting smokers with airflow limitation for smoking cessation
Source: Eur Respir J 2009; 33: 754-762
Year: 2009



The association between airflow limitation and dyspnea and comorbidity related to COPD in the Nagahama study
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


Night-time symptoms: a forgotten dimension of COPD
Source: Eur Respir Rev 2011; 20: 183-194
Year: 2011



Airflow limitation or dynamic hyperinflation, which is more closely related to dyspnoea in patients with COPD?
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


Respiratory symptoms, smoking habits and early COPD diagnosis in a community spirometry program
Source: Eur Respir J 2007; 30: Suppl. 51, 128s
Year: 2007

Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013

An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015



frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


How persistent is ²persistent airflow limitation² in severe asthma?
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006

Comorbidities impair physical activity in COPD irrespective of airflow limitation
Source: International Congress 2014 – Comorbidities
Year: 2014